Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

NEOGAP Therapeutics AB

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 1 More Arrow 241 More Arrow 1,275
Earnings before taxes -5,722 Less Arrow -11,444 Less Arrow -60,534
EBITDA -5,937 More Arrow -5,455 More Arrow -2,576
Total assets 105,542 More Arrow 122,156 Less Arrow 63,571
Current assets 22,306 More Arrow 56,105 Less Arrow 25,054
Current liabilities 9,219 More Arrow 20,110 Less Arrow 4,099
Equity capital 42,824 More Arrow 48,547 Less Arrow 5,973
- share capital 133 Equal arrow 133 Less Arrow 79
Employees (average) 17 Less Arrow 14 Equal arrow 14

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 40.6% Less Arrow 39.7% Less Arrow 9.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -5.4% Less Arrow -9.2% Less Arrow -93.2%
Current ratio 242.0% More Arrow 279.0% More Arrow 611.2%
Return on equity (ROE) -13.4% Less Arrow -23.6% Less Arrow -1013.5%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 3 Less Arrow 0 More Arrow 1
Chg. No. of employees % 21% Less Arrow 0% More Arrow 8%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.